Tudori Oprea News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Tudori oprea. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Tudori Oprea Today - Breaking & Trending Today

Researchers develop AI model to better predic

Data scientists at the Icahn School of Medicine at Mount Sinai in New York and colleagues have created an artificial intelligence model that may more accurately predict which existing medicines, not currently classified as harmful, may in fact lead to congenital disabilities. The model, or “knowledge graph,” described in the July 17 issue of the Nature journal Communications Medicine, also has the potential to predict the involvement of pre-clinical compounds that may harm the developing fetus. The study is the first known of its kind to use knowledge graphs to integrate various data types to investigate the causes of congenital disabilities. ....

New York , United States , New Zealand , The Mount , New Zealand General , New Providence , East Harlem , Daniel Jb Clarke , Sherryl Jenkins , Avi Maayan , Deanne Taylor , Tudori Oprea , Taha Mohseni Ahooyi , Giacomob Marino , John Erol Evangelista , Christopheg Lambert University Of New Mexico , Method Of Research , Merck Co , Icahn School Of Medicine At Mount Sinai , Praveen Kumar University Of New Mexico , Cristiang Bologa University Of New Mexico , Common Fund , Association Of American Medical Colleges , Pharmacological Sciences , National Institutes Of Health , Mount Sinai Center ,

UTEP and UNM Collaborate on Online Platform to Accelerate COVID-19 Drug Discovery


 EL PASO, Texas –Drug discovery researchers at The University of Texas at El Paso and the University of New Mexico have leveraged their expertise to develop a rapid online tool to accelerate the discovery of drug therapies for SARS-CoV-2, the virus that causes COVID-19.
REDIAL-2020 is an open-source online suite of computational models that will help scientists rapidly screen small molecules for their potential COVID-19-fighting properties. The platform is available as a web application through DrugCentral.org/Redial.
“REDIAL-2020 is a machine learning platform we developed to estimate the activities of drugs for anit-SARS-COV-2 activities,” said Suman Sirimulla, Ph.D., assistant professor of pharmaceutical sciences at UTEP’s School of Pharmacy. “The platform allows scientists from around the world to identify small molecules that can inhibit SARS-CoV-2, in order to develop new drugs or repurpose existing drugs to treat COVID-19.” ....

United States , Tudori Oprea , Suman Sirimulla , Department Of Internal Medicine , National Center , Texas Advanced Computing Center , University Of New Mexico , School Of Pharmacy , University Of Texas At El Paso , Translational Sciences , Us Army Test , University Of Texas At Austin , Translational Informatics Division , New Mexico , Internal Medicine , Nature Machine , Advancing Translational Sciences , Evaluation Command , ஒன்றுபட்டது மாநிலங்களில் , துறை ஆஃப் உள் மருந்து , தேசிய மையம் , பல்கலைக்கழகம் ஆஃப் புதியது மெக்ஸிகோ , பள்ளி ஆஃப் மருந்தகம் , பல்கலைக்கழகம் ஆஃப் டெக்சாஸ் இல் எல் பாசோ , மொழிபெயர்ப்பு அறிவியல் , எங்களுக்கு இராணுவம் சோதனை ,